QatarEnergy and ExxonMobil Sign Deal to Export Cypriot Gas to Europe via Egypt
QXO Launches Hostile Takeover Bid for BuildingProducts Rival Beacon
Crossroads Capitals Investment Thesis for Nebius Group NBIS Shows Positive Results
Applied Digital APLD Surges to AllTime High as AI Lease Revenues Reach 73 Billion
Strait of Hormuz Closure Could Drive Oil to New Highs in Summer Piper Sandler Suggests
US Monthly Retail Sales Report Points to Moderate Consumer Spending Growth
STAA Q1 2026 Earnings EPS Soars Past Estimates Stock Declines Despite Strong Beat
SCCG Q4 2025 Earnings Significant EPS Beat Despite Stock Decline
Victory Capital Holdings Inc VCTR Q1 2026 Earnings EPS Tops Estimates as Asset Manager Delivers Solid Profit Performance
Quaker Houghton KWR Q1 2026 Earnings Narrow EPS Miss Fails to Dampen Investor Sentiment as Stock Rises
PAVmed Q1 2026 Earnings WiderthanExpected Loss as Revenue Remains Absent
OppFi Inc Q1 2026 Earnings EPS Surpasses Estimates Amidst Solid Operational Performance
ConnectOne Bancorp Preferred CNOBP Edges Higher as Yield Seeks Support
CocaCola Consolidated COKE Slightly Lower at 17646 Consolidation Continues
Venu Holding Corporation VENU Holds Near Key Support Amid Modest Gains
American Rebel Holdings AREB Surges 26 as Penny Stock Finds New Buying Interest at 006
Guidewire Software GWRE Retreats Slightly Testing Support After Mixed Session
Consumer Credit Growth Surges in December Signaling Robust Holiday Spending
ASP Isotopes Q4 2025 Earnings PreRevenue Developer Reports WiderthanExpected Loss Yet Shares Rally 735
Western Digital WDC Surges 834 Momentum Building Toward Key Resistance
Tillys Inc TLYS Faces Selling Pressure Near Key Support Level
Reliance Global Group EZRA Shares Dip 25 as Stock Tests Key Support
Hershey HSY Rallies Over 4 Approaches Resistance After Finding Support
Blackstone Strategic Credit 2027 Term Fund BGB Holds Steady at 1134 as Market Waits for Catalysts
LSI Industries Inc LYTS Slides 170 as Stock Approaches Key Support Zone
Elevra Lithium ELVR Slides 668 as Selling Pressure Intensifies
Aclaris Therapeutics ACRS Gains 244 as Buyers Defend Key Support Zone